Literature DB >> 7588789

Changes in the composition of bilirubin-IX isomers during human prenatal development.

T Yamaguchi1, H Nakajima.   

Abstract

We analyzed the isomeric composition of bilirubin-IX in human fetal bile using HPLC. The approximate ratio of the bilirubin-IX isomers obtained from the fetal bile at 20 weeks of gestation was IX alpha, 6%; IX beta, 87%; IX gamma, 0.5%; and IX delta, 6%. From 15 to 22 weeks, bilirubin-IX beta was predominant and bilirubin-IX delta and bilirubin-IX alpha were also present in the bile as minor components. By 28 weeks, bilirubin-IX alpha constituted about 50% of the total bilirubin. There was a general correlation between fetal age and the proportion of bilirubin-IX alpha to bilirubin-IX beta in the bile and the small intestinal contents of fetuses. As development proceeded from mid-gestation to near term, the isomeric composition dramatically changed, with a decrease in the IX beta isomer and a subsequent increment of the IX alpha isomer. In contrast, the IX delta isomer changes little. Recently, we identified four forms of biliverdin reductase including two biliverdin-IX alpha reductases and two biliverdin-IX beta reductases in human liver cytosolic fractions [Yamaguchi, T., Komoda, Y. & Nakajima. H. (1994) J. Biol. Chem. 269, 24,343-24,348]. The proportion of the total activity of biliverdin-IX beta reductases to that of biliverdin-IX alpha reductases was considerably higher in the fetal, than in the adult liver.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588789     DOI: 10.1111/j.1432-1033.1995.467_2.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage?

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

2.  Multiple origins of green coloration in frogs mediated by a novel biliverdin-binding serpin.

Authors:  Carlos Taboada; Andrés E Brunetti; Mariana L Lyra; Robert R Fitak; Ana Faigón Soverna; Santiago R Ron; María G Lagorio; Célio F B Haddad; Norberto P Lopes; Sönke Johnsen; Julián Faivovich; Lucía B Chemes; Sara E Bari
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-13       Impact factor: 11.205

3.  Initial-rate kinetics of the flavin reductase reaction catalysed by human biliverdin-IXbeta reductase (BVR-B).

Authors:  O Cunningham; M G Gore; T J Mantle
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

4.  Enzymatic Activity and Thermodynamic Stability of Biliverdin IXβ Reductase Are Maintained by an Active Site Serine.

Authors:  Wen-Ting Chu; Natasha M Nesbitt; Dmitri V Gnatenko; Zongdong Li; Beibei Zhang; Markus A Seeliger; Seamus Browne; Timothy J Mantle; Wadie F Bahou; Jin Wang
Journal:  Chemistry       Date:  2017-01-11       Impact factor: 5.236

5.  Heme degradation enzyme biliverdin IXβ reductase is required for stem cell glutamine metabolism.

Authors:  Zongdong Li; Natasha M Nesbitt; Lisa E Malone; Dimitri V Gnatenko; Song Wu; Daifeng Wang; Wei Zhu; Geoffrey D Girnun; Wadie F Bahou
Journal:  Biochem J       Date:  2018-03-29       Impact factor: 3.857

6.  Biliverdin reductase: a major physiologic cytoprotectant.

Authors:  David E Baranano; Mahil Rao; Christopher D Ferris; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

Review 7.  Excretion of biliary compounds during intrauterine life.

Authors:  Rocio I R Macias; Jose J G Marin; Maria A Serrano
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

8.  BLVRB redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans.

Authors:  Song Wu; Zongdong Li; Dmitri V Gnatenko; Beibei Zhang; Lu Zhao; Lisa E Malone; Nedialka Markova; Timothy J Mantle; Natasha M Nesbitt; Wadie F Bahou
Journal:  Blood       Date:  2016-05-16       Impact factor: 22.113

9.  In silico and crystallographic studies identify key structural features of biliverdin IXβ reductase inhibitors having nanomolar potency.

Authors:  Natasha M Nesbitt; Xiliang Zheng; Zongdong Li; José A Manso; Wan-Yi Yen; Lisa E Malone; Jorge Ripoll-Rozada; Pedro José Barbosa Pereira; Timothy J Mantle; Jin Wang; Wadie F Bahou
Journal:  J Biol Chem       Date:  2018-02-27       Impact factor: 5.157

10.  Analysis of the Rana catesbeiana tadpole tail fin proteome and phosphoproteome during T3-induced apoptosis: identification of a novel type I keratin.

Authors:  Dominik Domanski; Caren C Helbing
Journal:  BMC Dev Biol       Date:  2007-08-06       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.